InspireMD to Present at the 26th Annual ROTH Conference
BOSTON, MA – March 6, 2014 – InspireMD, Inc. (NYSE MKT: NSPR) (“InspireMD” or the “Company”), today announced that its CEO, Alan Milinazzo, will be presenting at the 26th Annual ROTH Conference at the Ritz Carlton, Laguna Niguel in Dana Point, CA. The Company will present at 5:00 p.m. PT on Tuesday, March 11, 2014.
Investors unable to attend the ROTH Conference may listen in to the webcast, which can be found on the Investors section of the Company’s website at www.inspiremd.com/site_en/for-investors/. The webcast will be available for 90 days following the presentation.
About InspireMD, Inc.
InspireMD seeks to utilize its proprietary MGuard™ with MicroNet™ technology to make its products the industry standard for embolic protection and to provide a superior solution to the key clinical issues of current stenting in patients with a high risk of distal embolization, no reflow and major adverse cardiac events.
InspireMD intends to pursue applications of this MicroNet™ technology in coronary, carotid (CGuard™) and peripheral artery procedures. InspireMD’s common stock is quoted on the NYSE MKT under the ticker symbol NSPR.
Investor Contacts:
Todd Fromer / Garth Russell
KCSA Strategic Communications
Phone: 212-896-1215 / 212-896-1250
Email: tfromer@kcsa.com / grussell@kcsa.com
Media Contacts:
Lewis Goldberg / Samantha Wolf
KCSA Strategic Communications
Phone: 212-896-1216 / 212-896-1220
Email: lgoldberg@kcsa.com / swolf@kcsa.com